Feligen CR/P Vivant Lyophilisat et solvant pour solution injectable
Feligen CR/P Vivant Lyophilisat et solvant pour solution injectable
Authorised
- Felid herpesvirus 1, strain F2, Live
- Feline panleucopenia virus, strain LR 72, Live
- Feline calicivirus, strain F9, Live
Product identification
Medicine name:
Feligen CR/P Vivant Lyophilisat et solvant pour solution injectable
Feligen CR/P Vivant Lyofilisaat en oplosmiddel voor oplossing voor injectie
Feligen CR/P Vivant Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung
Active substance:
- Felid herpesvirus 1, strain F2, Live
- Feline panleucopenia virus, strain LR 72, Live
- Feline calicivirus, strain F9, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Felid herpesvirus 1, strain F2, Live5.00/log10 50% cell culture infectious dose1.00Vial
-
Feline panleucopenia virus, strain LR 72, Live3.70/log10 50% cell culture infectious dose1.00Vial
-
Feline calicivirus, strain F9, Live4.60/log10 50% cell culture infectious dose1.00Vial
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- 1 x 1 dose lyophilsate + 1 x 1 ml solvent. The vials is sealed with an elastomer cap and an aluminium bottle cap.
- 50 x 1 dose lyophilsate + 50 x 1 ml solvent. The vials is sealed with an elastomer cap and an aluminium bottle cap.
- 30 x 1 dose lyophilsate + 30 x 1 ml solvent. The vials is sealed with an elastomer cap and an aluminium bottle cap.
- 10 x 1 dose lyophilsate + 10 x 1 ml solvent. The vials is sealed with an elastomer cap and an aluminium bottle cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V140734
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
